$0.2950
-0.00160-0.54%
At close: -
$0.2979
0.002900.98%
After Hours: Jan 24, 4:51 PM EDT
Virpax Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Virpax Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-14 | $-0.43 | $-0.58 | 25.9 % |
Q4 | 2024-03-26 | $-3.87 | $-2.70 | -43.3 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Virpax Pharmaceuticals (VRPX) is scheduled to report earnings on March 25, 2025. The last reported earnings were for reported on November 14, 2024 for Q3.
The Actual EPS was $-0.43, which beat the estimate of $-0.58.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.